
Overview of Obesity
Run the List
00:00
GLP-1s and newer co-agonists' efficacy
Brooke describes semaglutide, liraglutide, and tirzepatide and expected 10–20% or greater weight loss.
Play episode from 10:40
Transcript

Brooke describes semaglutide, liraglutide, and tirzepatide and expected 10–20% or greater weight loss.